Chronic wounds remain a major health care challenge, especially for people with diabetes, who often experience delayed ...

A California gene-therapy pioneer has filed for bankruptcy. Eli Lilly and Astellas have already lined up bids to buy pieces ...

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...

Sangamo’s legal counsel is Cooley LLP and Richards, Layton & Finger, PA, its financial advisor is MERU, LLC, and its restructuring banker is Raymond James. Kurtzman Carson Consultants, LLC dba Verita ...

Sangamo Therapeutics will lay off 51 members of its workforce while retaining 77 people to continue work on the programs central to Astellas and Eli Lilly’s bids. In conjunction with plans to file for ...

Andson Biotech is revolutionizing mass spec workflows for biopharma and beyond. Our mission is to remove technical barriers so you can bring your most ambitious discoveries to life. With our ...

Each year, hundreds of thousands of Americans turn to bankruptcy as a last resort — a legal shield against crushing debt loads that can include high-rate credit card debt, mounting medical bills, or ...

In the 30 years since it was founded, Alamo Biologics LLC became part of San Antonio's robust regenerative-medicine industry, manufacturing products derived from placental tissue for use in wound care ...

Alamo Biologics filed for bankruptcy protection after a trade-secret lawsuit led to a multimillion-dollar collection fight.

In its annual Biotech Beyond Borders report, EY projects growth to continue throughout 2026, fueled primarily by the increased volume and value of M&A and licensing deals. (Techa Tungateja/GettyImages ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Fortnite is about to end another season and head into a new one, Chapter 7, Season 3. And ...

The Biotech Investment National Security Act would apply to biotechnology activities including pharmaceutical development, biologics manufacturing and clinical research and development. (Photo by ...